Diagnostics News and Research

RSS

Aspirin could be used to treat patients with severe tuberculosis infection

Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.

26 Mar 2019

Cardiff University launches Medicines Discovery Institute to develop new generation of drugs

Cardiff University is stepping up the development of new drugs for mental health and central nervous system conditions, with the launch of the Medicines Discovery Institute.

25 Mar 2019

Luxia Scientific partners with Life Genomics to commercialize microbiome-based tests in the Nordic countries

Luxia Scientific, a French biotech dedicated to improving wellbeing and health for all through the analysis and understanding of the microbiome, announced today that it has signed an exclusive distribution agreement with Life Genomics to commercialize « 1test1TM » in Nordic countries.

From Luxia Scientific 25 Mar 2019

Shaping new treatments for tuberculosis

To commemorate World TB Day, a Special Collection has been released by PLOS Medicine containing a series of articles that articulate the essential new steps in clinical research that will pave the way for the development of tomorrow's optimal treatment for all forms of tuberculosis.

25 Mar 2019

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable Eisai to use Cerveau's [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography scans to assess the status and progression of neurofibrillary tangles in the brain.

25 Mar 2019

QIAGEN highlights its global commitment to preventive screening, treatment for latent TB infection

QIAGEN N.V. recognized the annual World TB Day 2019 held on March 24 by highlighting its growing global commitment to preventive screening and treatment for latent tuberculosis (TB) infection, a widespread condition that can lead to active TB disease in vulnerable patients.

25 Mar 2019

Special Collection tracks development of new diagnostic tests for tuberculosis

The Cochrane Infectious Diseases Group (link is external) (CIDG), which has its editorial base at LSTM, helps prepare systematic reviews related to the diagnosis and treatment of tuberculosis.

25 Mar 2019

MSU professor receives NSF CAREER grant for biosensor diagnostics

One day, a technician in a small, rural hospital may be able to reliably diagnose breast cancer, Alzheimer's disease or traumatic brain injury using a tab of paper that would change color like a pH strip dipped in vinegar.

22 Mar 2019

Exploring pathophysiological factors that link sleep problems and Alzheimer's disease

A new article explores the pathophysiological factors that link sleep disturbances and Alzheimer's disease.

22 Mar 2019

Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births

Spontaneous preterm birth, defined as birth before 37 weeks of gestation, and the related complications, are the largest contributors to infant death in the United States and worldwide, according to the World Health Organization.

22 Mar 2019

VTT’s PreMed project introduces a corporate perspective to coordinate the use of health data

In Finland, the health data collected in national registries already serves fairly well the needs of clinical care and academic fundamental research, and statistical purposes.

22 Mar 2019

Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics

Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.

22 Mar 2019

Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

Ludwig Cancer Research released today the full breadth of findings to be presented by Ludwig researchers at this year's American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Ga., March 29 - April 3, 2019.

22 Mar 2019

Certain bacteria and immune factors in vagina may cause or protect against preterm birth

Seven types of bacteria and certain immune factors in a woman's vagina and cervix may be responsible for increasing the risk of spontaneous preterm birth or protect against it, according to a new study from the Perelman School of Medicine at the University of Pennsylvania and the University of Maryland School of Medicine.

22 Mar 2019

Q BioMed and Mannin Research collaborate with McMaster University to develop GDF15 biomarker glaucoma diagnostic kit

Q BioMed Inc., a commercial stage biotechnology acceleration development company, announced today that its technology partner Mannin Research Inc. has entered into a research collaboration with the Biointerfaces Institute at McMaster University in Ontario, Canada to develop a GDF15 biomarker diagnostic kit for monitoring glaucoma severity and progression.

From Q BioMed Inc. 21 Mar 2019

MilliporeSigma’s Milli-Q Connect enables remote, secure monitoring of lab performance

MilliporeSigma today announced a new cloud-based, remote lab water service and monitoring capability available on all Milli-Q® CLX 7000 clinical water purification systems.

From Merck 20 Mar 2019

Sphingotec reports new applications of bio-ADM at 39th ISICEM

Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.

20 Mar 2019

World's leading source of data on diagnosis, treatments for aortic dissection

What began with a modest hospital grant at the University of Michigan in 1996 is now the world's leading source of data on diagnosis, treatments and outcomes for a rare and dangerous cardiac condition.

20 Mar 2019

GARDP and Evotec partner to tackle growing threat of antimicrobial resistance

The Global Antibiotic Research and Development Partnership and Evotec AG are today announcing the formation of a new strategic public-private partnership to tackle the growing threat of antimicrobial resistance.

19 Mar 2019

TGen and ABL sign agreement to distribute new TB test technology

n an important step toward eradicating tuberculosis, the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories, to market and distribute TGen's patented Next Generation Sequencing-based TB test technology.

19 Mar 2019

Diagnostics News and Research

Aspirin could be used to treat patients with severe tuberculosis infection

Cardiff University launches Medicines Discovery Institute to develop new generation of drugs

Luxia Scientific partners with Life Genomics to commercialize microbiome-based tests in the Nordic countries

Shaping new treatments for tuberculosis

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

QIAGEN highlights its global commitment to preventive screening, treatment for latent TB infection

Special Collection tracks development of new diagnostic tests for tuberculosis

MSU professor receives NSF CAREER grant for biosensor diagnostics

Exploring pathophysiological factors that link sleep problems and Alzheimer's disease

Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births

VTT’s PreMed project introduces a corporate perspective to coordinate the use of health data

Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics

Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

Certain bacteria and immune factors in vagina may cause or protect against preterm birth

Q BioMed and Mannin Research collaborate with McMaster University to develop GDF15 biomarker glaucoma diagnostic kit

MilliporeSigma’s Milli-Q Connect enables remote, secure monitoring of lab performance

Sphingotec reports new applications of bio-ADM at 39th ISICEM

World's leading source of data on diagnosis, treatments for aortic dissection

GARDP and Evotec partner to tackle growing threat of antimicrobial resistance

TGen and ABL sign agreement to distribute new TB test technology

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News